Skip to main content
Official EU label nameGlossary entry 1093

ADAMANTANYL HYDROXYLTEREPHTHALAMIDE

This record confirms an official common ingredient name for EU cosmetic product labelling. It does not by itself confirm that the substance is permitted, unrestricted or safe.

Global evidence snapshot

The resolved identity has matching regulatory evidence in 0 of 13 indexed market datasets: 0 country records and 0 EU Annex records. Every result and evidence gap is listed below.

0 markets with evidence
Markets checked
13
Markets with evidence
0
Evidence gaps
13
Resolved identifiers
0

Resolved substance identity

Ingredient index records:
ADAMANTANYL HYDROXYLTEREPHTHALAMIDE
Cosmetic functions: ANTIOXIDANT; ANTI-SEBUM; SKIN PROTECTING

Adamantanyl Hydroxylterephthalamide is the organic compound that conforms to the formula:

1 matched or reported name
ADAMANTANYL HYDROXYLTEREPHTHALAMIDE

Each compound below is connected through an exact CosIng ingredient-name match and an exact PubChem synonym match. It is not inferred from a partial or similar name.

Adamantanyl hydroxylterephthalamide

Exact match
IUPAC name
1-N-(1-adamantyl)-4-N-hydroxybenzene-1,4-dicarboxamide
Molecular formula
C18H22N2O3
Molecular weight
314.4 g/mol
InChIKey
ISBGXXVZDVOSTH-UHFFFAOYSA-N
PubChem CID
11674052

Exact CosIng INCI name equals a PubChem synonym · Checked 2026-08-31

Regulatory evidence across markets

None of the 13 markets tracked here holds an imported rule under the name ADAMANTANYL HYDROXYLTEREPHTHALAMIDE.

That is a statement about this inventory, not about the law: no imported rule is not evidence that a substance is permitted. A rule may exist under a different name, under a CAS or EC number this glossary entry does not carry, or in a dataset not yet imported.

Take this record further

Screen in a formulaOpen standalone comparison

Official source and scope

Imported from Commission Implementing Decision (EU) 2025/1175 (dataset version EU 2025/1175). The glossary supplies common ingredient names for the ingredient list required by Article 19(1)(g); it is not an approval or safety list.

Open official Decision